You have 9 free searches left this month | for more free features.

Wet Macular Degeneration

Showing 1 - 25 of 3,798

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])

Not yet recruiting
  • Age-related Wet Macular Degeneration
  • CG-P5 peptide
  • +2 more
  • Augusta, Georgia
  • +3 more
Nov 13, 2023

Neovascular Age-related Macular Degeneration Trial (RRG001)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Nov 15, 2023

Single Injection of Faricimab for nAMD With Persisting Fluid

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Glostrup, Denmark
    Miklos Schneider
Nov 3, 2023

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Artificial Intelligence Diagnostic Aid

Not yet recruiting
  • Wet Macular Degeneration
  • +2 more
  • Macusense Assessment Software
  • London, Westminster, United Kingdom
    Guy's and St Thomas's NHS Foundation Trust
Dec 29, 2022

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Ophthalmic
  • IBI302
  • Suzhou, Jiangsu, China
    Innovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Neovascular Age-related Macular Degeneration Trial (PMC-403)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Jul 11, 2023

Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • AXT107 Low Dose
  • +2 more
  • (no location specified)
May 5, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • OCU-10-C-110 for Injection
  • Abilene, Texas
    Retina Research Institute of Texas
Jun 6, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

Suspended
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Intravitreal injection of IBI302(dose 1)
  • +3 more
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 17, 2023

Neovascular Age-related Macular Degeneration Trial (FT-003)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • FT-003
  • (no location specified)
Nov 21, 2022

Russian Registry of Patients With nAMD

Terminated
  • Neovascular Age-Related Macular Degeneration
  • nAMD
  • (no location specified)
Jan 16, 2023

Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration(nAMD)
  • HG202
  • Shanghai, Shanghai, China
  • +1 more
Sep 4, 2023

Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • SKG0106
  • Katy, Texas
  • +1 more
Aug 15, 2023

Neovascular Age-related Macular Degeneration Trial in Shanghai (LX102-C01 Injection)

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • LX102-C01 Injection
  • Shanghai, China
    Shanghai General Hospital, Shanghai Jiao Tong University School
Apr 14, 2023

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • AR-14034 SR implant lower dose
  • +3 more
  • (no location specified)
Mar 3, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Austin, Texas
    Retina Consultants of Austin
Jan 16, 2023

Neovascular Age-related Macular Degeneration Trial in Beijing (IBI333)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • IBI333
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Nov 28, 2022

Learn More About How Well Aflibercept 8 mg Works in Treating

Not yet recruiting
  • Visual Impairment
  • +2 more
  • Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Australia
  • +5 more
Oct 4, 2023

Macular Degeneration, Wet, Metamorphopsia Trial

Recruiting
  • Macular Degeneration, Wet
  • Metamorphopsia
    • Cuneo, Piedmont, Italy
      Ospedale Santa Croce
    Sep 20, 2022

    Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

    Recruiting
    • Neovascular Age-related Macular Degeneration (NVAMD)
    • Diabetic Macular Edema (DME)
    • Phoenix, Arizona
    • +4 more
    Jun 14, 2023

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022